Atossa Therapeutics, Inc.
ATOS
$1.66
$0.149.21%
Corporate Info
206 588 0256
107 Spring Street
Seattle, WA 98104
Seattle, WA 98104
United States
2008
Details
Health Care
Pharmaceuticals, Biotechnology and Life Sciences
12
Business Decription
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company’s lead drug candidate oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.